Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05360680
Title A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cue Biopharma
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Phoenix Arizona 85054 United States Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
Stanford Advanced Medicine Cancer Center Palo Alto California 94304 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Winship Cancer Institute Atlanta Georgia 30322 United States Details
Johns Hopkins University Baltimore Maryland 21231 United States Details
Mayo Clinic - Rochester Rochester Minnesota 55905 United States Details
Carol G. Simon Cancer Center - Morristown Medical Center Morristown New Jersey 07960 United States Details
Montefiore Medical Center Bronx New York 10461 United States Details
Carolina BioOncology Institute Huntersville North Carolina 28078 United States Details
Gabrail Cancer Center Canton Ohio 44718 United States Details
Cleveland Medical Center (University Hospitals) Cleveland Ohio 44106 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Northwest Medical Specialties, PLLC Tacoma Washington 98405 United States Details
Carbone Cancer Center Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field